CNE100002FV6
CNE100002FV6
SHANDONG BUCHANG PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 15.62B EUR | 15.4B EUR | 17.38B EUR |
Enterprise Value | 17.35B EUR | 17.98B EUR | 20.08B EUR |
Valuation Multiples | |||
Trailing P/E | 64.39x | 48.8x | 39.45x |
Forward P/E | -- | -- | -- |
Price to Sales | 1.39x | 1.36x | 1.49x |
Price to Book | 1.53x | 1.53x | 1.7x |
EV/Revenue | 1.55x | 1.59x | 1.72x |
EV/EBITDA | 11.89x | 12.35x | 12.86x |
Price to FCF (P/FCF) | 26.22x | 19.97x | 15.13x |
EV/FCF | 29.12x | 23.31x | 17.48x |
FCF Yield | 3.81% | 5.01% | 6.61% |